Ken Griffin Exscientia PLC Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Exscientia PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 500 shares of EXAI stock, worth $2,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 1,200
58.33%
Holding current value
$2,420
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXAI
# of Institutions
101Shares Held
33.5MCall Options Held
500Put Options Held
189K-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$27.5 Million0.13% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$27.5 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY4.47MShares$21.6 Million0.3% of portfolio
-
Baillie Gifford & CO3.85MShares$18.6 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.59MShares$7.7 Million17.85% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $593M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...